IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

FLEXSTEEL INDUSTRIES INC (FLXS)

Business Summary

Flexsteel Industries, Inc. is one of the largest residential furniture manufacturers, importers, and marketers in the U.S. The furniture industry is highly competitive and includes a large number of U.S. and foreign manufacturers and distributors, none of which dominate the market. The Company competes in markets with a large number of relatively small manufacturers; however, certain competitors have substantially greater sales volumes than the Company. The Company's products compete based on style, quality, comfort, functionality, price, delivery, service and durability. The Company's overall business is not considered materially seasonal.

The Company's primary competitors are not named individually in the filing, but the industry is described as highly competitive and fragmented. The Company believes its patented, guaranteed-for-life Blue Steel Spring, manufacturing and sourcing capabilities, facility locations, commitment to customers, product quality, consumer insights, innovation, delivery, service, value and experienced production, sales, marketing and management teams are some of its competitive advantages. The Company addresses different consumer groups through its core brand, Flexsteel, and several category-specific sub-brands: Zecliner, Statements, Zen, Perfect Match, and Pulse, all of which have unique value propositions tailored to specific consumer needs.

The Company operates in one reportable segment, furniture products. The Company's furniture products business involves the distribution of manufactured and imported products consisting of a broad line of furniture for the residential market. The Company generates revenue through the sale of these products nationwide through retail partners and online channels. The Company integrates manufactured products with finished products acquired from offshore suppliers who can meet quality specifications and lead-time requirements, offering customers a range of made-to-order manufactured goods and ready-to-deliver imported products.

The Company offers a wide assortment of product solutions for different areas within the home including stationary and motion sofas, loveseats, chairs, and sectionals, as well as bedroom furniture, dining tables and chairs, occasional and entertainment tables, and kitchen storage. For more than 130 years, Flexsteel has strived to create strong consumer value with unmatched quality, comfort, and durability, backed by innovation and highlighted by its patented Blue Steel Spring technology, designed to deliver lasting comfort and support. The Company's production includes the use of selected component parts sourced offshore to enhance value in the marketplace.

During the fiscal year ended June 30, 2026, the Company operated manufacturing facilities located in Juarez, Mexico. This ongoing manufacturing operation is integral to the Company's product offerings and distribution strategy by offering smaller and more frequent product runs of a wider product selection. The Company leases and operates three manufacturing facilities in Juarez, Mexico and leases one manufacturing facility in Mexicali, Mexico. The four Mexico facilities total 1,061,000 square feet. As of June 30, 2026, the Company has not begun operations in the Mexicali facility and expects to sublease the facility until such time that demand necessitates the additional capacity. The Company had approximately 900 employees located in Mexico on June 30, 2026. The Company also had approximately 30 employees located in Asia to ensure Flexsteel's quality standards are met and to coordinate the delivery of products acquired from overseas suppliers.

On December 11, 2024, the Board of Directors approved a share repurchase program authorizing the Company to purchase up to $30 million of the Company's common stock. On April 26, 2026, the Company entered into a stock repurchase agreement for the purchase by the Company of 1,279,870 shares of the Company's common stock in a privately-negotiated transaction at a purchase price of $47.00 per share and for a total purchase price of approximately $60.2 million . During the quarter ended March 31, 2025, the Company determined that the right of use asset related to its leased Mexicali, Mexico facility was not fully recoverable and recorded a pre-tax non-cash asset impairment charge of $14.1 million due to substantial changes in U.S. trade policy in early 2025. During the year ended June 30, 2025, the Company completed the sale of its Dublin, Georgia facility and recorded a pre-tax gain of $5.0 million related to the sale. The Company also completed the sale of 2 separate ancillary buildings, formerly part of its Huntingburg, Indiana distribution center complex, receiving proceeds of $0.8 million and recording a pre-tax gain of $0.7 million related to the first sale, and receiving proceeds of $4.0 million and recording a pre-tax gain of $3.7 million related to the second sale. Subsequent to fiscal year end, on August 18, 2026 the Company entered into a new $30.0 million secured revolving credit facility that replaces the Credit Agreement.

Net sales were $459.2 million for the year ended June 30, 2026, compared to net sales of $441.1 million in the prior year, an increase of $18.1 million or 4.1% . Gross margin for the year ended June 30, 2026, was 24.7% , compared to 22.2% for the prior fiscal year, an increase of 250 basis points . Net income was $33.1 million , or $6.07 per diluted share for the year ended June 30, 2026, compared to net income of $20.2 million , or $3.55 per diluted share in the prior year. Net cash provided by operating activities was $51.5 million for the fiscal year ended June 30, 2026.

Business Outlook & Financial Sufficiency

Management's focus for fiscal year 2027 will be to continue to operate with agility, maintain disciplined cost control, protect the Company's financial position, and invest in the capabilities that management believes will drive long-term growth and shareholder value creation.The Company's growth strategy includes investments in consumer insights, new products and marketing to execute its growth strategy, as noted in the MD&A discussion of SG&A expense increases. The Company continues to modernize its ERP systems, taking great care in the planning and execution of these updates. The Company is leveraging AI to strengthen the efficiency and effectiveness of its operational execution. The Company's blended focus on manufactured and imported products allows it to provide a wide range of price points, styles and product categories to satisfy customer requirements.

The Company's growth is supported by its manufacturing and sourcing capabilities. The Company integrates manufactured products with finished products acquired from offshore suppliers who can meet quality specifications and lead-time requirements. The Company will continue to pursue and refine this blended product offering and supply chain strategy, offering customers the requisite amount of choice of made-to-order manufactured goods, and ready-to-deliver imported products.

The 250-basis point increase in gross margin for fiscal 2026 was primarily driven by a 200-bps benefit from the IEEPA Tariff Refunds received and to a lesser extent favorable mix driven by product and customer portfolio optimization initiatives. SG&A expense as a percentage of net sales was 15.4% in fiscal year 2026 compared to 15.1% of net sales in the prior fiscal year, with the increase of 30-bps primarily due to a 70-bps benefit from fixed cost leverage on higher sales volume offset by 70-bps increase in investments in consumer insights, new products and marketing and a 30-bps increase from higher incentive compensation expense.

The Company identifies and eliminates manufacturing inefficiencies and adjusts manufacturing schedules frequently to meet customer requirements. The Company has established relationships with key suppliers to ensure prompt delivery of quality component parts. The Company's production includes the use of selected component parts sourced offshore to enhance value in the marketplace. The Company had approximately 1,200 employees on June 30, 2026, including 6 employees who are covered by collective bargaining agreements. Substantially all of the Company's employees are full-time.

Capital expenditures were $3.9 million for the fiscal year ended June 30, 2026. On December 11, 2024, the Board of Directors approved a share repurchase program authorizing the Company to purchase up to $30 million of the Company's common stock. As of June 30, 2026, $28,584,297 remained available for share repurchases under the program. Dividends paid were $4.4 million in fiscal 2026. The payment of future cash dividends is within the discretion of the Company's Board of Directors and will depend, among other factors, on its earnings, capital requirements and operating and financial condition.

The Company faces headwinds from changes in U.S. trade policy, including the imposition of tariffs and other trade restrictions. The majority of the Company's seating products sourced from Vietnam and manufactured in Mexico remain subject to the 25% Section 232 tariffs which, under the existing proclamation, is scheduled to increase to 30% effective January 1, 2027, unless modified prior to that date. Cost inflation, including significant increases in ocean container rates, tariffs, raw materials prices, labor rates, and domestic transportation costs, has and could continue to impact profitability. The Company's products are considered deferrable purchases for consumers during economic downturns, and prolonged negative economic conditions could affect consumer spending habits by decreasing the overall demand for home furnishing products.

The Company's participation in a multi-employer pension plan may have exposure under the plan that could extend beyond what its obligations would be with respect to its employees. Based on the most recent information available to the Company, the present value of actuarially accrued liabilities of the multi-employer pension plan substantially exceeds the value of the assets held in trust to pay benefits. The Company's obligations may be impacted by the funded status of the plans, the plans' investment performance, changes in the participant demographics, financial stability of contributing employers and changes in actuarial assumptions.

Management Sentiments & Priorities

Management's message emphasizes operating with agility, maintaining disciplined cost control, protecting the Company's financial position, and investing in capabilities that management believes will drive long-term growth and shareholder value creation. The strategic priorities for fiscal year 2027 include continuing to execute the growth strategy through investments in consumer insights, new products and marketing, while maintaining a focus on cost control and financial discipline. Management highlights the 250-basis point improvement in gross margin to 24.7% and the increase in net income to $33.1 million or $6.07 per diluted share as evidence of the Company's progress. The Company also emphasizes its commitment to returning capital to shareholders through the $30 million share repurchase program and regular dividends.

Financial Details

For the fiscal year ended June 30, 2026, total net sales were $459.2 million compared to $441.1 million in the prior year. Net income was $33.1 million compared to $20.2 million in fiscal 2025. Diluted earnings per share were $6.07 versus $3.55 in the prior year. Gross margin improved to 24.7% from 22.2% in fiscal 2025. Operating income was 9.3% of net sales compared to 6.0% in the prior year. Net cash provided by operating activities was $51.5 million compared to $37.0 million in fiscal 2025. The Company had no outstanding borrowings under its credit agreement as of June 30, 2026. Working capital was $82.7 million on June 30, 2026 compared to $110.4 million on June 30, 2025. Capital expenditures were $3.9 million for fiscal 2026. The effective tax rate was 24.4% compared to 25.3% in the prior year. The fiscal 2025 results included a pre-tax non-cash asset impairment charge of $14.1 million related to the Mexicali facility right-of-use asset and a pre-tax gain of $5.0 million on the sale of the Dublin, Georgia facility.

Risk Factors

Changes in U.S. trade policy, including tariffs, pose a material risk to the Company's business. The majority of seating products sourced from Vietnam and manufactured in Mexico are subject to a 25% Section 232 tariff scheduled to increase to 30% effective January 1, 2027, and case goods products from Vietnam are subject to Section 301 tariffs of either 10% or 12.5% . The Company's participation in a multi-employer pension plan presents a risk, as the present value of actuarially accrued liabilities substantially exceeds the value of assets held in trust to pay benefits . The Company recorded a $14.1 million impairment charge in fiscal 2025 on the Mexicali facility right-of-use asset, and the remaining carrying amount may not be recoverable if the facility cannot be subleased. The Company had $36.0 million in property, plant and equipment and $35.7 million in right-of-use assets at June 30, 2026, which are subject to impairment testing. The Company's ability to collect amounts owed to it is a risk, as customers may experience cash flow and credit-related issues, and the Company generally grants payment terms between 10 and 60 days without requiring collateral.

References

  1. [1] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  2. [2] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  3. [3] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  4. [4] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  5. [5] Item 7, MD&A — Fiscal 2025 Compared to Fiscal 2024
  6. [6] Item 7, MD&A — Fiscal 2025 Compared to Fiscal 2024
  7. [7] Item 7, MD&A — Fiscal 2025 Compared to Fiscal 2024
  8. [8] Item 7, MD&A — Fiscal 2025 Compared to Fiscal 2024
  9. [9] Item 7, MD&A — Fiscal 2025 Compared to Fiscal 2024
  10. [10] Item 7, MD&A — Fiscal 2025 Compared to Fiscal 2024
  11. [11] Item 7, MD&A — Liquidity and Capital Resources, Financing Arrangements
  12. [12] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  13. [13] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  14. [14] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  15. [15] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  16. [16] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  17. [17] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  18. [18] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  19. [19] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  20. [20] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  21. [21] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  22. [22] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  23. [23] Item 7, MD&A — Liquidity and Capital Resources
  24. [24] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  25. [25] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  26. [26] Item 7, MD&A — Liquidity and Capital Resources
  27. [27] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  28. [28] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  29. [29] Item 7, MD&A — Liquidity and Capital Resources, Net cash (used in) financing activities
  30. [30] Item 1A, Risk Factors — Changes in U.S. trade policy
  31. [31] Item 1A, Risk Factors — Multi-employer pension plan
  32. [32] Item 1A, Risk Factors — Impairment of long-lived assets
  33. [33] Item 1A, Risk Factors — Impairment of long-lived assets
  34. [34] Item 1A, Risk Factors — Impairment of long-lived assets
  35. [35] Item 1A, Risk Factors — Collection of amounts owed
  36. [36] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  37. [37] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  38. [38] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  39. [39] Item 5, Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  40. [40] Item 8, Consolidated Statements of Income and Comprehensive Income
  41. [41] Item 8, Consolidated Statements of Income and Comprehensive Income
  42. [42] Item 8, Consolidated Statements of Income and Comprehensive Income
  43. [43] Item 8, Consolidated Statements of Income and Comprehensive Income
  44. [44] Item 8, Consolidated Statements of Income and Comprehensive Income
  45. [45] Item 8, Consolidated Statements of Income and Comprehensive Income
  46. [46] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  47. [47] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  48. [48] Item 7, MD&A — Results of Operations (table)
  49. [49] Item 7, MD&A — Results of Operations (table)
  50. [50] Item 7, MD&A — Liquidity and Capital Resources
  51. [51] Item 7, MD&A — Liquidity and Capital Resources
  52. [52] Item 7, MD&A — Liquidity and Capital Resources
  53. [53] Item 7, MD&A — Liquidity and Capital Resources
  54. [54] Item 7, MD&A — Liquidity and Capital Resources
  55. [55] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  56. [56] Item 7, MD&A — Fiscal 2026 Compared to Fiscal 2025
  57. [57] Item 7, MD&A — Fiscal 2025 Compared to Fiscal 2024
  58. [58] Item 7, MD&A — Fiscal 2025 Compared to Fiscal 2024

Analysis on 8/19/2026